Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
04/2000
04/05/2000CN1249779A Cytochrome P450 monooxygenases
04/05/2000CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy
04/05/2000CN1249338A Process for efficiently extracting blood coagulation factor plus activating enzyme
04/04/2000US6046764 Visual inspection system of moving strip edges using cameras and a computer
04/04/2000US6046384 Papaya ringspot virus NIa protease gene
04/04/2000US6046382 Plants with modified flowers
04/04/2000US6046380 Dna which is modified at cryptic splice sites; for improved yield and gene therapy
04/04/2000US6046318 Isolated cdna which encodes a protein having one or more cysteine containing domains; for diagnosis, therapy, recombinant production, and as probes to isolate related proteins in other species and organisms
04/04/2000US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae
04/04/2000US6046044 Cisplatin resistance proteins
04/04/2000US6046042 Amino acid sequence; for preferentially producing (s)-cyanohydrins
04/04/2000US6046041 Efficient, inexpensive production of library of secosteroids and psuedoterosins by adding metabolic precursors to an enzyme composition from coral, and collecting produced compounds; without causing undue stress or harm to ecosystems
04/04/2000US6046040 Method for producing glycoconjugates
04/04/2000US6046036 For increasing survival rate of non-target cells such as hematopoietic cells when contacted with anticarcinogenic/dna-damaging agents during multiagent chemotherapy protocols or in fanconi's anemia
04/04/2000US6046031 Metalloproteinases
04/04/2000US6046029 Nucleic acids encoding human fatty acid synthase-like protein
04/04/2000US6046025 Expression of heterologous proteins in drosophila cells
04/04/2000US6046001 Human fatty acid beta-oxidation enzymes
04/04/2000US6045829 Having increased rate and uniformity of absorption in vivo
04/04/2000US6045798 Membrane-associated immunogens of mycobacteria
04/04/2000US6045794 Platelet-activating factor acetylhydrolase
04/04/2000US6045792 Human proteins kinases
04/04/2000CA2217746C Sugar compounds
04/04/2000CA2048676C Artificial promoter for the expression of proteins in yeast
04/04/2000CA2002540C Dna sequence coding for the human ix factor or a similar protein, expression vector, transformed cells, process for the preparation of ix factor and products obtained
04/04/2000CA1340948C Peptidylaminodiols
04/04/2000CA1340942C Processes for the treatment of vascular disease
04/04/2000CA1340940C Peptidylaminodiols
03/2000
03/30/2000WO2000017644A1 Ndp
03/30/2000WO2000017372A2 Pineapple mealybug-associated wilt virus proteins and their uses
03/30/2000WO2000017370A1 HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE)
03/30/2000WO2000017369A2 Alzheimer's disease secretase
03/30/2000WO2000017368A1 Orange fruit pectinacetylesterase
03/30/2000WO2000017367A1 Aspergillus tubigensis polygalacturonase
03/30/2000WO2000017366A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
03/30/2000WO2000017352A1 Plants capable of metabolizing drugs and utilization thereof
03/30/2000WO2000017344A1 RESPONSE REGULATOR $i(CaSSK1)
03/30/2000WO2000017343A1 Method for making insertional mutations
03/30/2000WO2000017332A1 Production of soluble recombinant trypsinogen analogs
03/30/2000WO2000017331A1 A 2,6-β-D-FRUCTAN HYDROLASE ENZYME AND PROCESSES FOR USING THE ENZYME
03/30/2000WO2000017330A1 Dna polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides
03/30/2000WO2000017329A1 Rec2 kinase
03/30/2000WO2000017328A2 Fibrils
03/30/2000WO2000017327A2 Terpene synthases
03/30/2000WO2000017320A2 Methods and reagents for inactivating ribonucleases
03/30/2000WO2000017319A2 Synthesis of vanillin from a carbon source
03/30/2000WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000WO2000017232A2 Regulatory protein from human keratinocytes
03/30/2000WO2000017228A2 Stereoselective process for enalapril
03/30/2000WO2000017215A1 Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection
03/30/2000WO2000017182A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
03/30/2000WO2000017150A1 NEW SALTS OF HMG-CoA REDUCTASE INHIBITORS
03/30/2000WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors
03/30/2000WO2000016733A2 Personal care compositions containing active proteins tethered to a water insoluble substrate
03/30/2000WO2000016641A1 Interactions between genotype and diet in swine that prevent e coli associated intestinal disease
03/30/2000WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
03/30/2000WO2000008196A3 Urate oxidase
03/30/2000WO1999067288A9 Tumor antigen peptides originating in cyclophilin b
03/30/2000WO1999063931A9 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
03/30/2000WO1999057287A3 Beta-glucosidase coding sequences and protein from orpinomyces pc-2
03/30/2000WO1999057285A3 Sucrose phosphate synthase
03/30/2000WO1999057281A3 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same
03/30/2000WO1999053055A3 Therapeutic agent for ngf
03/30/2000WO1999049047A3 Plant 1,3-beta-d-glucan synthase and brittle-1 encoding sequences
03/30/2000WO1999038980A3 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
03/30/2000CA2360539A1 Methods and reagents for inactivating ribonucleases
03/30/2000CA2344675A1 Personal care compositions containing active proteins tethered to a water insoluble substrate
03/30/2000CA2344674A1 Plants capable of metabolizing chemical substances and use thereof
03/30/2000CA2344665A1 Synthesis of vanillin from a carbon source
03/30/2000CA2344105A1 Dna polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides
03/30/2000CA2343966A1 Production of soluble recombinant trypsinogen analogs
03/30/2000CA2343937A1 Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection
03/30/2000CA2343936A1 Rec2 kinase
03/30/2000CA2343931A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae
03/30/2000CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000CA2343646A1 New salts of hmg-coa reductase inhibitors
03/30/2000CA2343645A1 Process for obtaining hmg-coa reductase inhibitors of high purity
03/30/2000CA2343321A1 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
03/30/2000CA2343193A1 Improved stereoselective process for enalapril
03/30/2000CA2343070A1 A 2,6-.beta.-d-fructan hydrolase enzyme and processes for using the enzyme
03/30/2000CA2343004A1 Alzheimer's disease secretase
03/30/2000CA2342957A1 Regulatory protein from human keratinocytes
03/30/2000CA2342053A1 Modified tobacco 5-epi-aristolochene synthases
03/29/2000EP0989184A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
03/29/2000EP0988859A1 Active substance preparations and a process for producing the same
03/29/2000EP0988548A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma
03/29/2000EP0988386A2 Nucleic acids encoding polypeptide having protease activity
03/29/2000EP0988385A2 Tace-like and matrilysin-like polypeptides
03/29/2000EP0988384A1 New beta-glucanase from a bacillus
03/29/2000EP0988383A1 Fumonisin detoxification compositions and methods
03/29/2000EP0988382A1 Human protein phosphatase ii-c-like protein
03/29/2000EP0988375A1 Acrylamidase enzymes
03/29/2000EP0988374A1 Hydrophilic composition containing protease produced by vibrio
03/29/2000EP0988373A1 Selection marker
03/29/2000EP0988372A1 Mammalian lysophosphatidic acid acyltransferase
03/29/2000EP0988366A1 Detersive enzyme particles having water-soluble carboxylate barrier layer and compositions including same
03/29/2000EP0988050A1 UTILIZATION OF $i(WOLINELLA SUCCINOGENES) ASPARAGINASE TO TREAT DISEASES ASSOCIATED WITH ASPARAGINE DEPENDENCE
03/29/2000EP0987936A1 Fatty acid desaturases and mutant sequences thereof
03/29/2000EP0602123B1 Steroid sulphatase inhibitors
03/29/2000CN1249003A Expression element
1 ... 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 ... 1416